United States · Venture startup
7 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$41Mraised across 7 rounds since 2007, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by finsmes.comSEC filing: $2.6M sold, first sale Mar 2012
Reported by masshightech.comSEC filing: $2.6M sold, first sale Mar 2012
No investor was named in the report.
Reported by masshightech.comSEC filing: $2.6M sold, first sale Mar 2012
No investor was named in the report.
Reported by masshightech.comSEC filing: $3.6M sold, first sale Aug 2011
No investor was named in the report.
Reported by masshightech.comSEC filing: $2.4M sold, first sale Dec 2010
No investor was named in the report.
Reported by sec.govSEC filing: $5.5M sold, first sale Jul 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Novartis Venture Fund
New Leaf Venture Partners
Connecticut Innovations
Alexandria Real Estate Equities
Aisling CapitalCHL Medical PartnersDsskjfmt
OpGenBrian DixonMissing a round, or an investor who was in one? Tell us.
BioRelix's investors include Novartis Venture Fund, New Leaf Venture Partners, Connecticut Innovations, Alexandria Real Estate Equities and Aisling Capital, and 4 more on record.
BioRelix has raised $41M across 7 rounds since 2007.
BioRelix's most recent round was a Venture of $269K in Apr 2012.
BioRelix's largest round on record is $26M (Series A), in Jun 2007.
BioRelix's first round on record, in Jun 2007, was backed by Novartis Venture Fund, New Leaf Venture Partners and Alexandria Real Estate Equities and 3 others.
BioRelix's latest named round is a Venture, in Apr 2012.
BioRelix is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·